U. S. Pharmacist’s cover photo
U. S. Pharmacist

U. S. Pharmacist

Book and Periodical Publishing

Lyndhurst, New Jersey 304 followers

Celebrating 50 Years of Pharmacy Excellence | The Pharmacist's Resource for Clinical Excellence

About us

U.S. Pharmacist is a peer-reviewed clinical journal for Pharmacists, committed to providing pharmacists with the highest quality clinical information. Our journal and digital programs deliver pharmacists with “need to know” information, relevant to the clinical aspects of today’s pharmacy practice, with the goal of improving patient care. U.S. Pharmacist original pharmacist authored articles focus on providing practical information for managing patients’ drug therapies, initiating preventive care, and improving treatment outcomes. Features and departments address Rx and OTC products, alternative and complementary therapies, compounding, acute patient care, long-term patient care, and outpatient pharmacy care. U.S. Pharmacist provides pharmacists education and clinical content needed to provide patient care, with Continuing Education featured in every issue. Visit www.uspharmacist.com for digital editions, CPE, Patient Teaching Aids and more!

Website
http://www.uspharmacist.com
Industry
Book and Periodical Publishing
Company size
11-50 employees
Headquarters
Lyndhurst, New Jersey
Type
Privately Held
Founded
1975
Specialties
Pharmacy, Pharmacists, Health Care, Pharmacist Patient Care, Pharmacist Continuing Education, Pharmacy Techs, Pharmacy Students, Pharmacist Education, Advertising, Publishing, Retail Pharmacist, Hospital Pharmacist, Consultant Pharmacist , Compounding Pharmacy, Health-System Pharmacist, Independent Pharmacist, Specialty Pharmacy, Oncology Pharmacy, Patient Education, Pharmacist, and PharmD

Locations

  • Primary

    160 Chubb Ave

    Suite 304

    Lyndhurst, New Jersey 07071, US

    Get directions

Employees at U. S. Pharmacist

Updates

  • 📢 The PBM Landscape is Shifting: What You Need to Know The "black box" of PBM pricing is finally facing some serious federal sunlight. With the Consolidated Appropriations Act (CAA), we are seeing a massive regulatory pivot toward transparent, fee-based models—a move that could fundamentally change how our pharmacies are reimbursed. In the April 2026 edition of U.S. Pharmacist, Michael Dowell (Partner at Hinshaw) breaks down exactly what this means for our profession. While the headlines focus on "transparency," the devil is in the details of the upcoming compliance shifts. Key Takeaways for Pharmacists: Reimbursement Evolution: How the shift away from spread pricing might stabilize retail pharmacy margins. - The 2028-2029 Horizon: New reporting obligations that will force PBMs to disclose more than ever before. - Compliance Risks: Understanding the new regulatory hurdles for entities under the CAA. - Advocacy & Action: What we need to do now to prepare for these long-term changes. As the frontline of patient care, we know all too well how PBM practices impact our ability to serve our communities. It’s time to get ahead of the legislative curve. Read the full analysis in this month’s column: https://lnkd.in/emA2bQS7 #Pharmacy #PBMReform #HealthcareLaw #USPharmacist #PharmacyOwner #DrugPricing

    View organization page for Hinshaw & Culbertson LLP

    15,049 followers

    The Consolidated Appropriations Act (CAA) introduces major reforms to pharmacy benefit manager (PBM) regulations, shifting toward transparent, fee-based PBM business models and creating new compliance risks for regulated entities. In a new column published in the April 2026 edition of U. S. Pharmacist, Hinshaw partner Michael Dowell discusses key regulatory changes, including new reporting obligations taking effect in 2028 and 2029, implications for retail and pharmacy reimbursement, compliance guidance, and more. Read his insights: https://lnkd.in/gxFX8xgC #HealthcareLaw #Pharmacy #PBM #Regulatory

    • The image features a photo of Michael Dowell standing next to text that reads, "How PBM Regulatory Reform Reshapes Pharmacy Reimbursement." The logos of U.S. Pharmacist and Hinshaw are also visible.
  • Cutting Through the TrumpRx Noise 🗣️ When something new enters the pharmacy landscape, confusion tends to move faster than facts. Since TrumpRx launched in February, independent pharmacies have been fielding questions and quietly asking: What does this mean for my bottom line? At its core, TrumpRx is a discount platform, not a prescription processor. It connects patients to affordability pathways—including TrumpRx-branded coupons for local retail pharmacies. GoodRx's Aaron Crittenden breaks down how these pathways actually work and why the facts are more reassuring than the headlines. ▶️Read the full article: https://ow.ly/8INa50YNX3o #IndependentPharmacy #TrumpRx #PharmacyBusiness #HealthcareTransparency

  • An uncomfortable truth for Asthma Awareness Month: up to 90% of patients are using their inhalers incorrectly. This isn't a failure of medication — it's a failure of education. And as pharmacists, you are uniquely positioned to correct it. In clinical practice, you have seen inhaler technique errors lead to: ❌ Perceived treatment failure ❌ Unnecessary escalation of therapy ❌ Preventable emergency visits What happens when we take five minutes to do a proper teach-back and device assessment: ✅ Better symptom control ✅ Reduced oral corticosteroid bursts ✅ Patients who finally feel like their medication is "working" A few high-yield counseling points for your team this month: • MDI users — slow, coordinated actuation and inhalation; spacers are underutilized and underrecommended • DPI users — forceful, deep inhalation; no shaking; no spacer • Soft mist inhalers — slow breath, different technique entirely Are you doing routine technique assessments in your pharmacy? If not, this month is the perfect time to start. 💬We'd love to hear from pharmacists who have implemented structured inhaler counseling programs. What's worked for your team? #AsthmaAwarenessMonth #InhalerTechnique #ClinicalPharmacy #PatientCounseling #RespiratoryHealth #PharmacyPractice #MedicationAdherence #PharmD #HealthcareEducation #AsthmaAwareness #InhalerEducation #PharmacyCare #RespiratoryTherapy #PatientSafety #PharmacistRole #InhalerUse #PharmacyTeam

  • May is Asthma Awareness Month — and I want to take a moment to recognize the often-underappreciated role pharmacists play in asthma management. With more than 25 million Americans affected by asthma, and emergency department visits for asthma attacks still numbering in the millions annually, the need for consistent, accessible, high-quality asthma care is undeniable. Pharmacists are uniquely positioned to bridge the gap between prescribers and patients. As pharmacists, you see patients more frequently, we can assess inhaler technique in real time, and are trained to identify warning signs of poorly controlled asthma before a crisis occurs. This month, U.S. Pharmacist is committed to sharing evidence-based content, patient counseling strategies, and clinical updates specifically for pharmacy professionals. Because when you do our jobs well, patients breathe better — and that's not a small thing. Follow along for weekly posts throughout May. And share below: How has your role in asthma care evolved in recent years? #AsthmaAwarenessMonth #PharmacyPractice #RespiratoryHealth #PatientCare #ClinicalPharmacy #PharmD #HealthcareLeadership #AsthmaManagement #CommunityHealth #PharmacistLife

    • No alternative text description for this image
  • #SponsoredByGSK Did you know that nearly 90% of Americans live within five miles of a pharmacy? 🏪 This proximity makes pharmacists the most accessible healthcare providers in the nation—and the ultimate solution to closing vaccine gaps. In a recent article, "Pharmacists as Frontline Champions," we explore how pharmacy teams are leveraging this unique position to reach patients who might otherwise fall through the cracks of the healthcare system. It's time to view the pharmacy counter as the front line of preventive care. Read the full article: https://lnkd.in/eubk7BSZ #PublicHealth #Pharmacist #Vaccines #HealthcareAccess #FrontlineHeroes

    • No alternative text description for this image
  • Stay up-to-date with the latest in pharmacy practice! 🩺 Dive into the newest Pharmacist Recommendation Series video from U.S. Pharmacist to explore the critical role of 505(b)(2) products in oncology and hematology. 💡 Pro-tip: Make sure to watch past minute three for a highly valuable 5-step checklist for 505(b)(2) products that you can implement right away to help in your practice! Watch the full breakdown here: https://ow.ly/wYGY50YGMo3 #Pharmacy #Pharmacist #Oncology #Hematology #ClinicalPharmacy #PharmacyEducation

  • Cutting Through the TrumpRx Noise 🗣️ When something new enters the pharmacy landscape, confusion tends to move faster than facts. Since TrumpRx launched in February, independent pharmacies have been fielding questions and quietly asking: What does this mean for my bottom line? At its core, TrumpRx is a discount platform, not a prescription processor. It connects patients to affordability pathways—including TrumpRx-branded coupons for local retail pharmacies. GoodRx's Aaron Crittenden breaks down how these pathways actually work and why the facts are more reassuring than the headlines. ▶️Read the full article: https://ow.ly/8INa50YNX3o #IndependentPharmacy #TrumpRx #PharmacyBusiness #HealthcareTransparency

  • New evidence pharmacists should watch this week A new nationwide cohort study found that continuous glucose monitoring use in adults with type 1 diabetes was associated with lower risks of diabetic ketoacidosis, cardiovascular disease, end-stage kidney disease, and all-cause mortality. The findings add to growing evidence supporting the clinical value of CGM in diabetes management. See the full US Pharmacist update: CGM Linked to Fewer Complications in Type 1 Diabetes. (Link in Comments) #USPharmacist #Pharmacy #TherapeuticUpdate #Diabetes #CGM #Type1Diabetes

    • No alternative text description for this image
  • Stay up-to-date with the latest in pharmacy practice! 🩺 Dive into the newest Pharmacist Recommendation Series video from U.S. Pharmacist to explore the critical role of 505(b)(2) products in oncology and hematology. 💡 Pro-tip: Make sure to watch past minute three for a highly valuable 5-step checklist for 505(b)(2) products that you can implement right away to help in your practice! Watch the full breakdown here: https://ow.ly/wYGY50YGMo3 #Pharmacy #Pharmacist #Oncology #Hematology #ClinicalPharmacy #PharmacyEducation

  • Empowering Health for All: The Pharmacist's Role. 🌍 Today is World Health Day. As we reflect on the global goal of "Health for All," it is impossible to ignore the evolving and critical role of the pharmacist. The profession has moved far beyond dispensing. Today, pharmacists are clinical leaders driving public health initiatives. Whether it is closing the gap on adult immunization rates, leading pharmacogenomics implementation, or providing critical MTM services to underserved populations, pharmacists are essential to an equitable healthcare system. When we empower pharmacists to practice at the top of their license, we dramatically improve patient access and outcomes. To all the clinical pharmacists, community pharmacy teams, and researchers working to advance human health: Happy World Health Day from U.S. Pharmacist. #WorldHealthDay #HealthEquity #HealthcareLeadership #ClinicalPharmacy #PublicHealth #PharmacyPractice #USPharmacist

    • No alternative text description for this image

Similar pages